Table 4.
References | n | TAC | ROS | cTn | CK-MB | LVEF | POAF | LOS ICU | LOS hospital |
---|---|---|---|---|---|---|---|---|---|
Shafiei et al. (25) | 58 | MDA | |||||||
Pasupathy et al. (27) | 112 | MDA | |||||||
Ozaydin et al. (36, 37) | 172 | TAC | TOS | ||||||
Kurian et al. (40) | 50 | SOD, GR | MDA | ||||||
Karahan et al. (49) | 44 | MDA | |||||||
Prabhu et al. (42) | 53 | GSH | MDA | ||||||
Köksal et al. (44) | 30 | GPX | MDA | ||||||
Koramaz et al. (48) | 30 | MDA | |||||||
Eren et al. (53) | 20 | MDA |
n, indicates sample size; ROS, reactive oxygen species; TAC, total antioxidant capacity; cTn, cardiac troponin; CK-MB, creatine kinase muscle band; LVEF, left ventricular ejection fraction; POAF, post-operative atrial fibrillation; LOS, length of stay; ICU, intensive care unit; SOD, superoxide dismutase; GR, glutathione reductase; GSH, reduced glutathione; GPX, glutathione peroxidase; MDA, malondialdehyde; TOS, total oxidative stress. indicates increase. indicates decrease. indicates minor increase. indicates no change.